{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:04:09Z","timestamp":1775581449941,"version":"3.50.1"},"reference-count":29,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pfizer and Bristol Myers Squibb"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2025.2514381","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:48:59Z","timestamp":1749199739000},"page":"859-870","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Nationwide extrapolation of economic benefit of therapeutic innovation: a\u00a010-year retrospective budget impact of direct oral anticoagulants introduction in France"],"prefix":"10.1080","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0501-4135","authenticated-orcid":false,"given":"C.","family":"Guilmet","sequence":"first","affiliation":[{"name":"Bristol-Myers Squibb","place":["Rueil-Malmaison, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lesage","sequence":"additional","affiliation":[{"name":"Public Health Expertise","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-4552","authenticated-orcid":false,"given":"F. E.","family":"Cott\u00e9","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb","place":["Rueil-Malmaison, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moreau","sequence":"additional","affiliation":[{"name":"Formerly at Public Health Expertise","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-8605","authenticated-orcid":false,"given":"C.","family":"Marant Micallef","sequence":"additional","affiliation":[{"name":"Formerly at Public Health Expertise","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-501X","authenticated-orcid":false,"given":"M.","family":"N\u00e9e","sequence":"additional","affiliation":[{"name":"PELyon","place":["Lyon, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Guitard-Dehoux","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb","place":["Rueil-Malmaison, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-5464","authenticated-orcid":false,"given":"M.","family":"Belhassen","sequence":"additional","affiliation":[{"name":"PELyon","place":["Lyon, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-5051","authenticated-orcid":false,"given":"N.","family":"Danchin","sequence":"additional","affiliation":[{"name":"Hopital Paris St Joseph","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04302.x"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.022"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1878-6480(16)30330-5"},{"key":"e_1_3_3_5_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. ELIQUIS (apixaban) 2018. [Internet]. [cited 2024 Jun 24]. https:\/\/www.has-sante.fr\/jcms\/c_2826829\/fr\/eliquis-apixaban"},{"key":"e_1_3_3_6_1","unstructured":"VIDAL. FANV: les AOD en 1re intention comme les AVK selon la nouvelle fiche de bon usage de la HAS. [Internet]. [cited 2024 Jun 20]. https:\/\/www.vidal.fr\/actualites\/22732-fanv-les-aod-en-1re-intention-comme-les-avk-selon-la-nouvelle-fiche-de-bon-usage-de-la-has.html"},{"key":"e_1_3_3_7_1","unstructured":"https:\/\/ansm.sante.fr\/uploads\/2021\/01\/13\/bon-usage-avk-actualisee-juillet-2012.pdf"},{"key":"e_1_3_3_8_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Les anticoagulants oraux. [Internet]. [cited 2024 Jul 22] https:\/\/www.has-sante.fr\/jcms\/c_2851086\/fr\/les-anticoagulants-oraux"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.923891"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.028825"},{"key":"e_1_3_3_11_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. ELIQUIS (apixaban) 2020. [Internet]. [cited 2024 Jul 23]. https:\/\/www.has-sante.fr\/jcms\/p_3199558\/fr\/eliquis-apixaban"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-022-01513-2"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111634"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-021-01002-z"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2014.04.009"},{"key":"e_1_3_3_16_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. ELIQUIS (apixaban) 2013. [Internet]. [cited 2024 Jun 20]. https:\/\/www.has-sante.fr\/jcms\/c_1616483\/fr\/eliquis-apixaban-anticoagulant-par-voie-orale"},{"key":"e_1_3_3_17_1","unstructured":"ISPOR | International Society For Pharmacoeconomics and Outcomes Research. Principles of Good Practice for Budget Impact Analysis I. [Internet][cited 2025 Jan 2]. https:\/\/www.ispor.org\/heor-resources\/good-practices\/article\/principles-of-good-practice-for-budget-impact-analysis"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.023495"},{"key":"e_1_3_3_19_1","unstructured":"BdM_IT: Liste. [Internet]. [cited 2024 Jun 26]. http:\/\/www.codage.ext.cnamts.fr\/codif\/bdm_it\/\/fiche\/index_lis_medisoc.php?p_code_cip=&p_nom_commercial=ELIQUIS&p_nb=4&p_site=AMELI&p_homol_ass=ass&p_homol_coll="},{"key":"e_1_3_3_20_1","unstructured":"M\u00e9dicaments d\u00e9livr\u00e9s par les pharmacies de ville par classe ATC - Medic\u2019AM - 2012 \u00e0 2024 (s\u00e9rie labellis\u00e9e) | L\u2019Assurance Maladie. [Internet]. 2024. https:\/\/www.assurance-maladie.ameli.fr\/etudes-et-donnees\/medicaments-classe-atc-medicam"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.7175\/fe.v17i3.1280"},{"key":"e_1_3_3_22_1","unstructured":"Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation Cardiac risk factors and prevention [Internet] 2024. [cited 2024 Dec 10]. https:\/\/www.researchgate.net\/publication\/344954833_Clinical_and_budget_impacts_of_changes_in_oral_anticoagulation_prescribing_for_atrial_fibrillation_Cardiac_risk_factors_and_prevention"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14585"},{"key":"e_1_3_3_24_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Choix m\u00e9thodologiques pour l\u2019analyse de l\u2019impact budg\u00e9taire \u00e0 la HAS. [Internet]. 2016 [cited 2025 May 9]. https:\/\/www.has-sante.fr\/jcms\/c_2730306\/fr\/choix-methodologiques-pour-l-analyse-de-l-impact-budgetaire-a-la-has"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S47385"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316340"},{"key":"e_1_3_3_27_1","unstructured":"INED. Vieillissement de la population en France. https:\/\/www.ined.fr\/fichier\/s_rubrique\/31978\/ined.cpr.septembre.2021.fr.pdf"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jce.15759"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2024.10.327"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2021.12.001"}],"updated-by":[{"DOI":"10.1080\/13696998.2025.2524268","type":"addendum","label":"Addendum","source":"publisher","updated":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000}}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2514381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:49:11Z","timestamp":1766400551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2514381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2514381"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2514381","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}